Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials.

Liberman, U A; Hochberg, M C; Geusens, P; Shah, A; Lin, J; Chattopadhyay, A; Ross, P D

Liberman, U A; Hochberg, M C; Geusens, P; Shah, A; Lin, J; Chattopadhyay, A; Ross, P D.

Affiliation

Liberman UA; Felsenstein Medical Research Center, Department of Physiology & Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. uliberm@post.tau.ac.il

Int J Clin Pract ; 60(11): 1394-400, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17026515

Subject(s)

Bone Density Conservation Agents/therapeutic use; Fractures, Bone/prevention & control; Osteoporosis, Postmenopausal/drug therapy; Aged; Aged, 80 and over; Female; Fractures, Bone/etiology; Hip Fractures/etiology; Hip Fractures/prevention & control; Humans; Osteoporosis, Postmenopausal/complications; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Fractures, Bone / Bone Density Conservation Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Aged80 / Female / Humans Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2006 Document type: Article Affiliation country: Israel Country of publication: India

Search on Google

Add to My VHL

XML

PubMed Links